Advertisement
UK markets close in 11 minutes
  • FTSE 100

    8,037.04
    -7.77 (-0.10%)
     
  • FTSE 250

    19,704.81
    -94.91 (-0.48%)
     
  • AIM

    754.23
    -0.64 (-0.08%)
     
  • GBP/EUR

    1.1635
    +0.0007 (+0.06%)
     
  • GBP/USD

    1.2438
    -0.0014 (-0.11%)
     
  • Bitcoin GBP

    52,306.33
    -1,286.57 (-2.40%)
     
  • CMC Crypto 200

    1,407.94
    -16.16 (-1.13%)
     
  • S&P 500

    5,058.32
    -12.23 (-0.24%)
     
  • DOW

    38,347.97
    -155.72 (-0.40%)
     
  • CRUDE OIL

    82.59
    -0.77 (-0.92%)
     
  • GOLD FUTURES

    2,347.00
    +4.90 (+0.21%)
     
  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     
  • HANG SENG

    17,201.27
    +372.34 (+2.21%)
     
  • DAX

    18,073.32
    -64.33 (-0.35%)
     
  • CAC 40

    8,083.68
    -22.10 (-0.27%)
     

Checking in with Sanofi’s Diabetes and Cardiovascular Business in 3Q17

Sanofi’s diabetes and cardiovascular franchises include the blockbuster diabetes drug Lantus, which contributes ~70% of all revenues for diabetes products.